583 artigos
Phase 3 trial compared therapeutic vaccine OSE2101 to chemotherapy in 219 lung cancer patients after immunotherapy failure.
Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.
Small Yale study tested magic mushroom compound for chronic headaches after brain injury, tracking symptoms and inflammation markers.
Yale researchers tested psilocybin's effects on OCD symptoms in a controlled trial, exploring potential therapeutic benefits.
Swiss researchers tested whether paroxetine reduces LSD response by downregulating serotonin receptors in healthy adults.
Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.
Swiss researchers tested LSD-assisted therapy for anxiety disorders in a controlled crossover trial with 46 participants.
UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
New study reveals how structured exercise enhances neuroprotective hormones and cognitive capacity in just 12 weeks.
